⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28121819 | 0.97 | — | — | |
| SCHEMBL2125566 | 0.89 | — | — | |
| SCHEMBL6561816 | 0.81 | — | — | |
| SCHEMBL10932455 | 0.69 | TRIM24 (0.41) | — | |
| SCHEMBL24120035 | 0.69 | LIPE (0.38) | — | |
| SCHEMBL119955 | 0.68 | — | — | |
| SCHEMBL7981543 | 0.68 | — | — | |
| SCHEMBL19902042 | 0.67 | — | — | |
| SCHEMBL362028 | 0.67 | PKM (0.40) | — | |
| SCHEMBL68353 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170327501-A1 | CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS | PHOENIX MOLECULAR DESIGNS (CA) | 2017-11-16 | — | — | US | disclosed |
| WO-2017141116-A1 | CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS | PHOENIX MOLECULAR DESIGNS (CA) | 2017-08-24 | — | — | WO | disclosed |
| US-20170240549-A1 | TETRAHYDROPYRIDO[3',2':4,5]PYRROLO[1,2-a]PYRAZINE-2-CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS | PHOENIX MOLECULAR DESIGNS (CA) | 2017-08-24 | — | — | US | disclosed |
| CN-103254062-A | Method of inhibiting polymerization and fouling in acrylic acid and acrylate processes | ARKEMA INC | 2013-08-21 | — | — | CN | disclosed |
| EP-2433940-A1 | SPIROIMIDAZOLONE DERIVATIVE | Chugai Seiyaku Kabushiki Kaisha (JP) | 2012-03-28 | — | — | EP | disclosed |
| CN-101878190-A | Method for inhibiting polymerization and fouling in acrylic acid and acrylate processes | ARKEMA INC | 2010-11-03 | — | — | CN | disclosed |
| EP-1272187-B1 | DOPAMINE-D3 RECEPTOR LIGANDS FOR THE TREATMENT OF ADDICTION | ABBOTT GMBH & CO KG (DE) | 2008-07-30 | — | — | EP | disclosed |
| EP-1480972-B1 | COMPOUNDS POSSESSING AFFINITY AT 5HT1-TYPE RECEPTORS AND USE THEREOF IN THERAPY OF CNS DISORDERS | GLAXO GROUP LTD (GB) | 2007-04-11 | — | — | EP | disclosed |
| EP-1246801-A2 | METHODS FOR THE SYNTHESES OF ALFENTANIL, SUFENTANIL AND REMIFENTANIL | MALLINCKRODT INC. (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001040184-A2 | METHODS FOR THE SYNTHESES OF ALFENTANIL, SUFENTANIL AND REMIFENTANIL | MALLINCKRODT INC. (US) | 2001-06-07 | — | — | WO | disclosed |
| US-4405737-A | OLEFIN STABILIZERS | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1983-09-20 | — | — | US | disclosed |
| EP-0058434-A1 | N-2-hydroxypropyl piperidines and process for preparing the same | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1982-08-25 | — | — | EP | disclosed |
| US-4332942-A | 3-(2-Hydroxy-4-(substituted)phenyl)azacycloalkanes as analgesics | PFIZER, INC. (US) | 1982-06-01 | — | — | US | disclosed |